Error loading player: No playable sources found
The Power of Proper System Suitability Tests - A Case Study of cGMP Method Improvement
Date
April 21, 2021
This product is not available for individual purchase, but it is available as part of the following products:
System suitability assessment is an essential part of bioassay methods. The choice of system suitability parameters and their ranges is critical for ensuring the quality of bioassay results. In this talk, we share a case study of successful bioassay method remediation, which significantly improved a legacy commercial method by replacing inappropriate system suitability criteria with state of the art new criteria. The talk provides an overview of the legacy method investigation, as well as determination, justification and implementation of the new system suitability criteria.
Session Speaker
Bristol-Myers Squibb Company
Related Products
Session IV: Bioassays for Vaccines and Antibody Therapies with Discussion
The pandemic of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has significantly impacted the lives of the global human population…
Enhancing the Speed of Vaccine Development by Utilizing Fully Automated High throughput Cell Potency Assays
High-throughput analytical assays are one of the key enabling strategies which are needed to support vaccine development…
